3 Stocks That Quadrupled
The stock market continues to put on a clinic about how to stomp all over expectations. The Dow Jones Industrial Average is up 25% this year and the S&P 500 is 20% higher, but stack them up next to Nektar Therapeutics (NASDAQ: NKTR), Esperion Therapeutics (NASDAQ: ESPR), and Sangamo Therapeutics (NASDAQ: SGMO), and the market index returns look quaint.
Let's look more closely at these three biotechs to see whether there's any more room to run after quadrupling so far in 2017.
Source: Fool.com
Sangamo Therapeutics Inc. Stock
€0.48
2.350%
Based on 11 Buy predictions and 12 Sell predictions the sentiment towards Sangamo Therapeutics Inc. is rather balanced.
On the other hand, the target price of 2 € is above the current price of 0.48 € for Sangamo Therapeutics Inc., so the potential is actually 312.97%.
